Counterpulsation
Intra-Aortic Balloon Pumping
Coronary-Subclavian Steal Syndrome
Angina Pectoris
Heart-Assist Devices
Myocardial Infarction
Encyclopedias as Topic
The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. (1/70)
OBJECTIVES: The purpose of this study was to assess safety and efficacy of enhanced external counterpulsation (EECP). BACKGROUND: Case series have shown that EECP can improve exercise tolerance, symptoms and myocardial perfusion in stable angina pectoris. METHODS: A multicenter, prospective, randomized, blinded, controlled trial was conducted in seven university hospitals in 139 outpatients with angina, documented coronary artery disease (CAD) and positive exercise treadmill test. Patients were given 35 h of active counterpulsation (active CP) or inactive counterpulsation (inactive CP) over a four- to seven-week period. Outcome measures were exercise duration and time to > or =1-mm ST-segment depression, average daily anginal attack count and nitroglycerin usage. RESULTS: Exercise duration increased in both groups, but the between-group difference was not significant (p > 0.3). Time to > or =1-mm ST-segment depression increased significantly from baseline in active CP compared with inactive CP (p = 0.01). More active-CP patients saw a decrease and fewer experienced an increase in angina episodes as compared with inactive-CP patients (p < 0.05). Nitroglycerin usage decreased in active CP but did not change in the inactive-CP group. The between-group difference was not significant (p > 0.7). CONCLUSIONS: Enhanced external counterpulsation reduces angina and extends time to exercise-induced ischemia in patients with symptomatic CAD. Treatment was relatively well tolerated and free of limiting side effects in most patients. (+info)Stabilisation of medically refractory ventricular arrhythmia by intra-aortic balloon counterpulsation. (2/70)
OBJECTIVE: To review the efficacy of intra-aortic balloon counterpulsation (IABCP) in medically refractory ventricular arrhythmia. DESIGN: Retrospective analysis of the outcome of patients with ventricular arrhythmia treated with IABCP after transfer between 1992 and 1997. SETTING: Tertiary cardiac referral centre. PATIENTS: 21 patients (mean age 58 years) who underwent IABCP for control of ventricular arrhythmia. All had significant left ventricular impairment (mean ejection fraction 28.6%); 18 had coronary artery disease. RESULTS: Before IABCP, 10 patients had incessant monomorphic ventricular tachycardia and 11 had paroxysmal ventricular tachycardia and/or ventricular fibrillation (VT/VF). IABCP resulted in suppression of ventricular arrhythmia in 18 patients, of whom 13 were weaned from IABCP. After stabilisation of ventricular arrhythmia, 10 patients were maintained on medical treatment alone and one underwent endocardial resection. IABCP was maintained until cardiac transplantation in five patients. One patient had a fatal arrest before discharge and one died from progressive heart failure. IABCP failed to control ventricular arrhythmia in three patients and was subsequently discontinued. A cardiac assist device was employed in one of these until cardiac transplantation; the other two were eventually stabilised on medical treatment. Nineteen patients were discharged from hospital. Overall survival was 95% at mean follow up of 25.7 months. CONCLUSIONS: IABCP can be an effective means of controlling refractory ventricular arrhythmia, allowing time for the institution of more definitive treatment. (+info)Improvement of regional myocardial and coronary blood flow reserve in a patient treated with enhanced external counterpulsation: evaluation by nitrogen-13 ammonia PET. (3/70)
Enhanced external counterpulsation (EECP) is a noninvasive treatment for chronic stable angina, which works by recruiting and developing the coronary collateral vessels. Coronary perfusion and coronary flow reserve (CFR) were evaluated by nitrogen-13 (13N) ammonia positron emission tomography (PET) in a patient who had undergone EECP. The patient, who had 3-vessel coronary artery disease, required a percutaneous transluminal coronary angioplasty (PTCA) for the right coronary artery. The PTCA was successful, but 6 months later he again felt chest oppression. The coronary angiography showed re-stenosis at the PTCA site, and other progressive coronary stenosis. The patient was again treated with EECP for 35 h. The 13N-ammonia PET was performed both at baseline and during dipyridamole provocation, before and after EECP treatment. Coronary perfusion of each myocardial wall increased at the baseline (anterior: 0.52-0.75; septal: 0.48-0.66; lateral: 0.61-0.68; inferior: 0.46-0.57 ml min(-1) g(-1), and the CFRs in the septal and inferior walls (septal: 2.07-2.15; inferior: 1.99-2.06) also increased after the treatment. Thus, the EECP treatment improved both coronary perfusion at baseline and CFR, which suggests that it may be one of the choices for treatment of angina. (+info)Cardiogenic shock triggered by verapamil and atenolol: a case report of therapeutic experience with intravenous calcium. (4/70)
Cardiogenic shock developed in a 72-year-old Japanese woman during combination therapy with verapamil and atenolol for recurrent supraventricular arrhythmia. She had coronary atherosclerosis, liver cirrhosis and bradycardia-tachycardia syndrome. Despite of the high-dose catecholamines and counterpulsation, she progressively deteriorated. Bolus administration of intravenous calcium chloride (CaCl2) immediately resolved her hemodynamic collapse. (+info)Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease. (5/70)
OBJECTIVES: We examined whether enhanced external counterpulsation (EECP) improves myocardial ischemia, exercise tolerance and cardiac function in patients with coronary artery disease (CAD). BACKGROUND: Enhanced external counterpulsation reduces angina and improves exercise tolerance in patients with CAD. Some objective improvements of ischemia by EECP have been reported, but they should be confirmed further. Detailed hemodynamic effects of EECP have been less well documented. METHODS: Enhanced external counterpulsation was performed for a total of 35 h in patients with stable CAD (n = 12) who showed evidence of exercise-induced myocardial ischemia despite conventional medical or surgical therapies. All patients had significant stenotic lesions in major coronary arteries. RESULTS: Enhanced external counterpulsation improved all exercise test parameters (p < 0.05): exercise duration, time to 1-mm ST segment depression, rate-pressure product at peak exercise and rate-pressure product at 1-mm ST segment depression. Moreover, the prevalence of exercise-induced reversible perfusion defects by thallium scintigraphy decreased after treatment (p < 0.01). Enhanced external counterpulsation did not alter systolic function but improved diastolic filling, left ventricular (LV) end-diastolic pressure (p < 0.05) by cardiac catheterization and LV peak filling rate end-diastolic volume/s (p < 0.01) and time to peak filling rate (p < 0.05) by radionuclide scintigraphy. These hemodynamic improvements were associated with decreased plasma brain natriuretic peptides levels after EECP (p < 0.05). CONCLUSIONS: Thus, EECP treatment improves exercise tolerance and reduced myocardial ischemia by thallium scintigraphy in association with improved LV diastolic filling in patients with stable CAD. (+info)Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina; evaluation by(13)N-ammonia positron emission tomography. (6/70)
AIMS: The mechanism by which enhanced external counterpulsation therapy exerts its beneficial effects on chronic and symptomatic stable angina is largely unknown. To clarify the mechanism of action of enhanced external counterpulsation, we used(13)N-ammonia positron emission tomography to evaluate myocardial perfusion. METHODS AND RESULTS: This was not a randomized controlled study. Eleven patients (eight male, age: 61.6+/-9.7) with angina pectoris underwent enhanced external counterpulsation therapy for 35 1 h sessions. They underwent a treadmill exercise test and(13)N-ammonia positron emission tomography, both at rest and with dipyridamole, before and after enhanced external counterpulsation therapy. Neurohumoral factors and nitric oxide were also evaluated. Myocardial perfusion increased at rest after therapy (0.69+/-0.27 to 0.85+/-0.47 ml x min(-1) x g(-1), P<0.05). In ischaemic regions, particularly the anterior region, myocardial perfusion at rest and with dipyridamole and coronary flow reserve improved significantly after therapy (at rest: 0.71+/-0.26 to 0.86+/-0.31;P<0.05, with dipyridamole: 1.26+/-0.65 to 1.84+/-0.94;P<0.02, coronary flow reserve: 1.75+/-0.24 to 2.08+/-0.28;P<0.04). Exercise time was prolonged and the time to 1-mm ST depression improved markedly (P<0.01). After therapy, nitric oxide levels increased (P<0.02) and neurohumoral factors decreased. CONCLUSIONS: Enhanced external counterpulsation therapy improved myocardial perfusion at rest and with dipyridamole and was associated with an increased exercise tolerance with(13)N-ammonia positron emission tomography and increased nitric oxide levels. These results suggest that one of the enhanced external counterpulsation mechanisms is development and recruitment of collateral vessels. (+info)Left ventricular systolic unloading and augmentation of intracoronary pressure and Doppler flow during enhanced external counterpulsation. (7/70)
BACKGROUND: Enhanced external counterpulsation (EECP) is a noninvasive, pneumatic technique that provides beneficial effects for patients with chronic, symptomatic angina pectoris. However, the physiological effects of EECP have not been studied directly. We examined intracoronary and left ventricular hemodynamics in the cardiac catheterization laboratory during EECP. METHODS AND RESULTS: Ten patients referred for diagnostic evaluation underwent left heart catheterization and coronary angiography from the radial artery. At baseline and then during EECP, central aortic pressure, intracoronary pressure, and intracoronary Doppler flow velocity were measured using a coronary catheter, a sensor-tipped high-fidelity pressure guidewire, and a Doppler flow guidewire, respectively. Similar to changes in aortic pressure, EECP resulted in a dramatic increase in diastolic (71+/-10 mm Hg at baseline to 137+/-21 mm Hg during EECP; +93%; P<0.0001) and mean intracoronary pressures (88+/-9 to 102+/-16 mm Hg; +16%; P=0.006) with a decrease in systolic pressure (116+/-20 to 99+/-26 mm Hg; -15%; P=0.002). The intracoronary Doppler measure of average peak velocity increased from 11+/-5 cm/s at baseline to 23+/-5 cm/s during EECP (+109%; P=0.001). The TIMI frame count, a quantitative angiographic measure of coronary flow, showed a 28% increase in coronary flow during EECP compared with baseline (P=0.001). CONCLUSIONS: EECP unequivocally and significantly increases diastolic and mean pressures and reduces systolic pressure in the central aorta and the coronary artery. Coronary artery flow, determined by both Doppler and angiographic techniques, is increased during EECP. The combined effects of systolic unloading and increased coronary perfusion pressure provide evidence that EECP may serve as a potential mechanical assist device. (+info)Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. (8/70)
OBJECTIVES: The goal of this study was to examine the effect of enhanced external counterpulsation (EECP) on endothelial function. BACKGROUND: Enhanced external counterpulsation improves symptoms and exercise tolerance in patients with symptomatic coronary artery disease (CAD). However, the exact mechanisms by which this technique exerts its clinical benefit are unclear. METHODS: Reactive hyperemia-peripheral arterial tonometry (RH-PAT), a noninvasive method to assess peripheral endothelial function by measuring reactive hyperemic response in the finger, was performed in 23 patients with refractory angina undergoing a 35-h course of EECP. In each patient RH-PAT measurements were performed before and after the first, at midcourse, and the last EECP session. In addition, RH-PAT response was assessed one month after completion of EECP therapy; RH-PAT index, a measure of reactive hyperemia, was calculated as the ratio of the digital pulse volume during reactive hyperemia divided by that at rest. RESULTS: Enhanced external counterpulsation led to symptomatic improvement (>/=1 Canadian Cardiovascular Society class) in 17 (74%) patients; EECP was associated with a significant immediate increase in average RH-PAT index after each treatment (p < 0.05). In addition, average RH-PAT index at one-month follow-up was significantly higher than that before EECP therapy (p < 0.05). When patients were divided by their clinical response, RH-PAT index at one-month follow-up increased only in those patients who experienced clinical benefit. CONCLUSIONS: Enhanced external counterpulsation enhances peripheral endothelial function with beneficial effects persisting at one-month follow-up in patients with a positive clinical response. This suggests that improvement in endothelial function may contribute to the clinical benefit of EECP in patients with symptomatic CAD. (+info)Counterpulsation is a medical treatment used in critical care medicine, particularly in the management of cardiovascular conditions. It refers to a technique that involves delivering therapies that counter or oppose the patient's own cardiac cycle. The most common form of counterpulsation is through the use of an intra-aortic balloon pump (IABP).
During IABP, a catheter with a sausage-shaped balloon at its tip is inserted into the patient's aorta, usually through the femoral artery in the groin. The balloon is then connected to a console that controls its inflation and deflation. The console is programmed to detect the patient's cardiac cycle using either the ECG or arterial pressure waveform.
During diastole (when the heart muscle relaxes and fills with blood), the balloon inflates, increasing the volume of blood in the aorta and improving coronary artery perfusion. This helps to increase oxygen delivery to the myocardium (heart muscle) and reduce its workload.
During systole (when the heart muscle contracts and ejects blood), the balloon deflates, reducing afterload (the resistance against which the heart must pump). This reduces the workload of the left ventricle, allowing it to fill more easily during diastole and improving overall cardiac output.
In summary, counterpulsation is a medical intervention that uses therapies, such as intra-aortic balloon pumps, to counter or oppose the patient's own cardiac cycle. This technique aims to improve coronary artery perfusion, reduce afterload, and enhance overall cardiac function.
Intra-aortic balloon pumping (IABP) is a form of short-term mechanical circulatory support that is used in patients with cardiogenic shock or acute complications of coronary artery disease, such as acute mitral regurgitation or papillary muscle rupture. It involves the insertion of a specialized catheter into the aorta, which contains a sausage-shaped balloon at its tip.
The IABP is synchronized with the patient's ECG and inflates the balloon during diastole (when the heart relaxes) and deflates it during systole (when the heart contracts). By inflating the balloon during diastole, the IABP increases the diastolic pressure in the aorta, which improves coronary perfusion and myocardial oxygen supply. By deflating the balloon during systole, the IABP reduces afterload, which decreases the work of the left ventricle and improves cardiac output.
Overall, IABP can help to stabilize patients with acute heart failure or cardiogenic shock while more definitive treatments are being planned or implemented. However, it is not a long-term solution and carries risks such as infection, bleeding, and limb ischemia.
Assisted circulation refers to the use of mechanical devices to help maintain or improve the circulation of blood in the body. This is often used when the heart is unable to pump blood effectively on its own, such as during cardiogenic shock or during certain surgical procedures.
There are several types of assisted circulation devices, including:
1. Intra-aortic balloon pump (IABP): A catheter with a balloon at the tip is inserted into the aorta and inflated and deflated in sync with the heartbeat to help reduce the workload on the heart and improve blood flow to the coronary arteries.
2. Ventricular assist devices (VADs): These are mechanical pumps that are implanted in the chest to help support the function of one or both ventricles of the heart. VADs can be used as a bridge to transplant, meaning they are used temporarily while a patient waits for a heart transplant, or as a destination therapy, meaning they are used as a long-term treatment option.
3. Extracorporeal membrane oxygenation (ECMO): This is a type of life support that uses a machine to pump blood outside the body and add oxygen to it before returning it to the body. ECMO can be used to support both heart and lung function in critically ill patients.
It's important to note that while assisted circulation devices can help improve blood flow and support heart function, they are not a cure for heart disease or other underlying conditions. They are typically used as a temporary measure to help stabilize a patient until more permanent treatment options can be explored.
Cardiogenic shock is a serious condition characterized by the inability of the heart to pump enough blood to meet the body's needs. It is a type of shock that originates from a primary cardiac dysfunction, such as severe heart muscle damage (myocardial infarction or heart attack), abnormal heart rhythms (arrhythmias), or acute valvular insufficiency.
In cardiogenic shock, the low cardiac output leads to inadequate tissue perfusion and oxygenation, resulting in multiple organ dysfunction and failure. Symptoms of cardiogenic shock include severe hypotension (low blood pressure), cool extremities, decreased urine output, altered mental status, and signs of congestive heart failure such as shortness of breath, cough, and peripheral edema.
Cardiogenic shock is a medical emergency that requires prompt diagnosis and immediate treatment, which may include medications to support blood pressure and heart function, mechanical assist devices, or even emergency heart transplantation in some cases.
Coronary-subclavian steal syndrome is a rare condition that occurs when there is narrowing or blockage in the subclavian artery, which supplies blood to the arm. This reduced blood flow can cause the vertebral artery, which branches off from the subclavian artery and supplies blood to the brain, to reverse its flow and "steal" blood from the vertebral artery on the opposite side of the body in order to supply blood to the affected arm.
When this occurs, it can result in insufficient blood flow to the brain, which can cause symptoms such as dizziness, lightheadedness, syncope (fainting), and even transient ischemic attacks (TIAs) or strokes. The syndrome is more commonly seen in older individuals with atherosclerosis, hypertension, or diabetes, and in those who have undergone coronary artery bypass graft surgery using the internal mammary artery as the conduit.
Diagnosis of coronary-subclavian steal syndrome typically involves imaging studies such as duplex ultrasound, computed tomography angiography (CTA), or magnetic resonance angiography (MRA) to visualize the blood flow in the affected vessels. Treatment may involve surgical or endovascular procedures to restore normal blood flow to the arm and brain.
Angina pectoris is a medical term that describes chest pain or discomfort caused by an inadequate supply of oxygen-rich blood to the heart muscle. This condition often occurs due to coronary artery disease, where the coronary arteries become narrowed or blocked by the buildup of cholesterol, fatty deposits, and other substances, known as plaques. These blockages can reduce blood flow to the heart, causing ischemia (lack of oxygen) and leading to angina symptoms.
There are two primary types of angina: stable and unstable. Stable angina is predictable and usually occurs during physical exertion or emotional stress when the heart needs more oxygen-rich blood. The pain typically subsides with rest or after taking prescribed nitroglycerin medication, which helps widen the blood vessels and improve blood flow to the heart.
Unstable angina, on the other hand, is more severe and unpredictable. It can occur at rest, during sleep, or with minimal physical activity and may not be relieved by rest or nitroglycerin. Unstable angina is considered a medical emergency, as it could indicate an imminent heart attack.
Symptoms of angina pectoris include chest pain, pressure, tightness, or heaviness that typically radiates to the left arm, neck, jaw, or back. Shortness of breath, nausea, sweating, and fatigue may also accompany angina symptoms. Immediate medical attention is necessary if you experience chest pain or discomfort, especially if it's new, severe, or persistent, as it could be a sign of a more serious condition like a heart attack.
Heart-assist devices, also known as mechanical circulatory support devices, are medical equipment designed to help the heart function more efficiently. These devices can be used in patients with advanced heart failure who are not responding to medication or other treatments. They work by taking over some or all of the heart's pumping functions, reducing the workload on the heart and improving blood flow to the rest of the body.
There are several types of heart-assist devices, including:
1. Intra-aortic balloon pumps (IABPs): These devices are inserted into the aorta, the large artery that carries blood from the heart to the rest of the body. The IABP inflates and deflates in time with the heartbeat, helping to improve blood flow to the coronary arteries and reduce the workload on the heart.
2. Ventricular assist devices (VADs): These devices are more invasive than IABPs and are used to support the function of one or both ventricles, the lower chambers of the heart. VADs can be used to support the heart temporarily while a patient recovers from surgery or heart failure, or they can be used as a long-term solution for patients who are not candidates for a heart transplant.
3. Total artificial hearts (TAHs): These devices replace both ventricles and all four valves of the heart. TAHs are used in patients who are not candidates for a heart transplant and have severe biventricular failure, meaning that both ventricles are no longer functioning properly.
Heart-assist devices can be life-saving for some patients with advanced heart failure, but they also carry risks, such as infection, bleeding, and device malfunction. As with any medical treatment, the benefits and risks of using a heart-assist device must be carefully weighed for each individual patient.
Myocardial infarction (MI), also known as a heart attack, is a medical condition characterized by the death of a segment of heart muscle (myocardium) due to the interruption of its blood supply. This interruption is most commonly caused by the blockage of a coronary artery by a blood clot formed on the top of an atherosclerotic plaque, which is a buildup of cholesterol and other substances in the inner lining of the artery.
The lack of oxygen and nutrients supply to the heart muscle tissue results in damage or death of the cardiac cells, causing the affected area to become necrotic. The extent and severity of the MI depend on the size of the affected area, the duration of the occlusion, and the presence of collateral circulation.
Symptoms of a myocardial infarction may include chest pain or discomfort, shortness of breath, nausea, lightheadedness, and sweating. Immediate medical attention is necessary to restore blood flow to the affected area and prevent further damage to the heart muscle. Treatment options for MI include medications, such as thrombolytics, antiplatelet agents, and pain relievers, as well as procedures such as percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).
Coronary circulation refers to the circulation of blood in the coronary vessels, which supply oxygenated blood to the heart muscle (myocardium) and drain deoxygenated blood from it. The coronary circulation system includes two main coronary arteries - the left main coronary artery and the right coronary artery - that branch off from the aorta just above the aortic valve. These arteries further divide into smaller branches, which supply blood to different regions of the heart muscle.
The left main coronary artery divides into two branches: the left anterior descending (LAD) artery and the left circumflex (LCx) artery. The LAD supplies blood to the front and sides of the heart, while the LCx supplies blood to the back and sides of the heart. The right coronary artery supplies blood to the lower part of the heart, including the right ventricle and the bottom portion of the left ventricle.
The veins that drain the heart muscle include the great cardiac vein, the middle cardiac vein, and the small cardiac vein, which merge to form the coronary sinus. The coronary sinus empties into the right atrium, allowing deoxygenated blood to enter the right side of the heart and be pumped to the lungs for oxygenation.
Coronary circulation is essential for maintaining the health and function of the heart muscle, as it provides the necessary oxygen and nutrients required for proper contraction and relaxation of the myocardium. Any disruption or blockage in the coronary circulation system can lead to serious consequences, such as angina, heart attack, or even death.
An encyclopedia is a comprehensive reference work containing articles on various topics, usually arranged in alphabetical order. In the context of medicine, a medical encyclopedia is a collection of articles that provide information about a wide range of medical topics, including diseases and conditions, treatments, tests, procedures, and anatomy and physiology. Medical encyclopedias may be published in print or electronic formats and are often used as a starting point for researching medical topics. They can provide reliable and accurate information on medical subjects, making them useful resources for healthcare professionals, students, and patients alike. Some well-known examples of medical encyclopedias include the Merck Manual and the Stedman's Medical Dictionary.
In the context of human anatomy, the thigh is the part of the lower limb that extends from the hip to the knee. It is the upper and largest portion of the leg and is primarily composed of the femur bone, which is the longest and strongest bone in the human body, as well as several muscles including the quadriceps femoris (front thigh), hamstrings (back thigh), and adductors (inner thigh). The major blood vessels and nerves that supply the lower limb also pass through the thigh.
A tourniquet is a device or material used to apply pressure around an extremity, typically an arm or leg, with the goal of controlling severe bleeding (hemorrhage) by compressing blood vessels and limiting arterial flow. Tourniquets are usually applied as a last resort when direct pressure and elevation have failed to stop life-threatening bleeding. They should be used cautiously because they can cause tissue damage, nerve injury, or even amputation if left on for too long. In a medical setting, tourniquets are often applied by healthcare professionals in emergency situations; however, there are also specialized tourniquets available for use by trained individuals in the military, first responder communities, and civilians who have undergone proper training.
External counterpulsation
Intra-aortic balloon pump
Virtua Our Lady of Lourdes Hospital
Impella
Outline of cardiology
Leslie Lam (doctor)
Maquet
Adrian Kantrowitz
Pulmonary artery catheter
ECP
Adventist HealthCare Shady Grove Medical Center
Ricardo Armentano
List of MeSH codes (E04)
External counterpulsation - Wikipedia
Stabilisation of medically refractory ventricular arrhythmia by intra-aortic balloon counterpulsation | Heart
Enhanced External Counterpulsation Eases 'Long COVID' - Physician's Weekly
Intra-aortic balloon counterpulsation in patients with acute myocardial infarction and cardiogenic shock | Cochrane
Extra-aortic balloon counterpulsation: an intra-operative feasibility study.
No Benefit for Routine Counterpulsation Found in CRISP AMI « CardioExchange
Intra-aortic balloon counterpulsation for cardiogenic shock due to cardiac contusion in an elderly trauma patient<...
Biaya Enhanced External Counter Pulsation (EECP) di Balikpapan - Rumah Sakit Terbaik - Alodokter
External Counterpulsation Therapy (ECP) Per Session - iElder.Asia
external counterpulsation therapy for wellness Archives - ECPTherapy.com
side effects of external counterpulsation therapy Archives - ECPTherapy.com
A study to assess the effectiveness of structured teaching program on external counter pulsation therapy among staff nurse...
Intra‐aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock | Cochrane...
Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease<...
CABG - Coronary Artery Bypass Graft
External Counterpulsation Increases Beat-to-Beat Heart Rate Variability in Patients with Ischemic Stroke<...
Right Ventricular Infarction: Background, Pathophysiology, Epidemiology
Raia P[au] - Search Results - PubMed
Prevention Services | MN Heart
Christian A. Bermudez, MD profile | PennMedicine.org
Table - Extracorporeal Membrane Oxygenation for Pandemic (H1N1) 2009 - Volume 15, Number 12-December 2009 - Emerging Infectious...
Virtua Cardiology - Pennsauken
Articles from Arifur Rahman | Selfgrowth.com - Page 3
Datascope/Getinge Recalls Cardiosave Hybrid and Rescue Intra-Aortic Balloon Pumps (IABP) for Risk That Blood May Enter Pump...
Myocardial ischemia | Sparrow
Peripartum cardiomyopathy: MedlinePlus Medical Encyclopedia
Table of Contents - April 13, 2004, 170 (8) | CMAJ
External Counterpulsation Therapy3
- External counterpulsation therapy (ECP) is a procedure that may be performed on individuals with angina, heart failure, or cardiomyopathy. (wikipedia.org)
- This risk free treatment is called EECP (Enhanced External Counterpulsation Therapy) or ECP (External Counterpulsation Therapy). (ielder.asia)
- EECP (Enhanced External Counterpulsation Therapy) is most often used in the U.S for the treatment of advanced Coronary Artery Disease in patients that are no longer candidates for surgical intervention. (ecptherapy.com)
Balloon10
- OBJECTIVE To review the efficacy of intra-aortic balloon counterpulsation (IABCP) in medically refractory ventricular arrhythmia. (bmj.com)
- Intra-aortic balloon counterpulsation (IABCP) improves coronary flow and reduces myocardial distension, thus potentially influencing ventricular irritability by direct and indirect effects. (bmj.com)
- Intra-aortic balloon pump counterpulsation (IABP) is currently the most commonly used mechanical assist device for patients with cardiogenic shock due to acute myocardial infarction. (cochrane.org)
- Extra-aortic balloon counterpulsation: an intra-operative feasibility study. (auckland.ac.nz)
- Routine use of intra-aortic balloon counterpulsation (IABC) in STEMI patients who do not have cardiogenic shock does not reduce infarct size, according to a new trial. (jwatch.org)
- The use of intra-aortic balloon counterpulsation (IABCP) as a mechanical means of augmenting cardiac function following cardiac contusion is rare with case reports largely limited to its use in young trauma patients. (edu.au)
- Penney, DJ, Bannon, PG & Parr, MJA 2002, ' Intra-aortic balloon counterpulsation for cardiogenic shock due to cardiac contusion in an elderly trauma patient ', Resuscitation , vol. 55, no. 3, pp. 337-340. (edu.au)
- Cochrane Abstracts , Evidence Central , evidence.unboundmedicine.com/evidence/view/Cochrane/431771/all/Intra‐aortic_balloon_pump_counterpulsation__IABP__for_myocardial_infarction_complicated_by_cardiogenic_shock. (unboundmedicine.com)
- Intraaortic balloon counterpulsation. (nih.gov)
- On the basis of type, the market is segmented into, Balloon pumps, Cardiopulmonary bypass pumps, Cardiac ultrasound devices, Implantable Cardioverter Defibrillator (ICD), Cardiac Resynchronization Therapy (CRT) Devices such as CRT Pacemaker (CRT-P) and CRT Defibrillator (CRT-D), Defibrillators Pacemakers, Ventricular assist devices and others such as Total Artificial Heart and Counterpulsation Devices. (alliedmarketresearch.com)
IABP Counterpulsation2
- In the presence of ongoing ischemia or left ventricular dysfunction, pre-operative IABP counterpulsation therapy can provide myocardial protection by reducing perioperative myocardial ischemia, stabilizing hemodynamics and improving coronary perfusion. (getinge.com)
- In this webinar, Dr. Joseph L. Thomas presents his expert opinion, the physiologic basis for pre-operative IABP counterpulsation and the existing clinical data in support of this treatment strategy. (getinge.com)
Coronary6
- Methods and Results- In 6 patients undergoing first time off-pump coronary bypass surgery via sternotomy, the EAB was secured around the ascending aorta and attached to a standard counterpulsation console. (auckland.ac.nz)
- Conclusions- EAB counterpulsation augments coronary flow and reduces left ventricular afterload. (auckland.ac.nz)
- BACKGROUND: Enhanced external counterpulsation improves symptoms and exercise tolerance in patients with symptomatic coronary artery disease (CAD). (elsevierpure.com)
- Abstract Enhanced external counterpulsation (EECP) is able to treat myocardial ischemia, which is usually caused by coronary artery stenosis. (techscience.com)
- However, the underlying mechanisms regarding why this technique is effective in treating myocardial ischemia remains unclear and there is no patient-specific counterpulsation mode for different rates of coronary artery stenosis in clinic. (techscience.com)
- This study sought to investigate the hemodynamic effect of varied coronary artery stenosis rates when using EECP and the necessity of adopting targeted counterpulsation mode to consider different rates of coronary artery stenosis. (techscience.com)
Therapy1
- ECP is a non-invasive and non-surgical therapy process that use a medical device approved by the FDA and KKM to deliver External CounterPulsation to enhance blood flow through timed inflation of cuffs wrapped around the calves, thighs, and hips. (ielder.asia)
Acute myocardial1
- Results from the CRISP AMI (Counterpulsation to Reduce Infarct Size Pre-PCI Acute Myocardial Infarction) trial were presented at the European Society of Cardiology meeting in Paris by Manesh Patel and published simultaneously in JAMA . (jwatch.org)
Patients4
- MONDAY, Feb. 28, 2022 (HealthDay News) - For patients with "long COVID," enhanced external counterpulsation (EECP) treatment is associated with improvement in symptoms, including fatigue and breathing difficulties, according to a study presented at the American College of Cardiology virtual Cardiovascular Summit, held Feb. 16 to 19. (physiciansweekly.com)
- In an ESC press statement, Patel said that the trial did not support the use of routine IABC, adding: "Physicians should be vigilant about identifying those patients who are at risk for rapid deterioration and may benefit from counterpulsation. (jwatch.org)
- CONCLUSIONS: Enhanced external counterpulsation enhances peripheral endothelial function with beneficial effects persisting at one-month follow-up in patients with a positive clinical response. (elsevierpure.com)
- Passive tobacco exposure may impair symptomatic improvement in patients with chronic angina undergoing enhanced external counterpulsation. (bvsalud.org)
Angina1
- The Renew leg external counterpulsation device got clearance from the FDA for use in healthy people, beyond its current stable angina indication. (medpagetoday.com)
Perfusion2
- Does Enhanced External Counterpulsation (EECP) Significantly Affect Myocardial Perfusion? (wikipedia.org)
- abstract = "{\textcopyright} 2017 National Stroke AssociationBackground and Purpose External counterpulsation (ECP) is a noninvasive method used to augment cerebral perfusion in ischemic stroke. (edu.hk)
Background1
- Background- Current methods of counterpulsation or ventricular assistance have significant vascular and limb complications. (auckland.ac.nz)
EECP9
- Does Enhanced External Counterpulsation (EECP) Significantly Affect Myocardial Perfusion? (wikipedia.org)
- However, the hemodynamic effects of EECP are similar to those of intra-aortic balloon counterpulsation, with similar diastolic augmentation and afterload reduction. (medscape.com)
- Endothelial function may improve with enhanced external counterpulsation (EECP) or acupuncture. (nih.gov)
- Enhanced External Counterpulsation (EECP) is a non-invasive, FDA-approved outpatient therapy to reduce the intensity and frequency of angina-related chest pain. (flowtherapy.com)
- This risk free treatment is called EECP (Enhanced External Counterpulsation Therapy) or ECP (External Counterpulsation Therapy). (ielder.asia)
- 6. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis. (nih.gov)
- External counterpulsation systems developer Vasomedical introduced its Electronic Communication Module for the EECP Therapy System. (urgentcomm.com)
- The FDA-cleared EECP external counterpulsation therapy is a non-invasive therapeutic option for angina and heart-failure patients, according to the company. (urgentcomm.com)
- Dr. Poon will purchase an enhanced external counterpulsation (EECP) machine. (stonybrook.edu)
Evolution of Counterpulsation Techniques1
- The Evolution of Counterpulsation Techniques. (nih.gov)
Intra-aortic balloon2
- Intra-aortic balloon counterpulsation is the most common form of mechanical circulatory support (MCS) used in the setting of myocardial ischemia and cardiogenic shock. (medscape.com)
- Intra-aortic balloon counterpulsation (IAoBC) is a mechanical circulatory support device that has been used for more than 50 years, mainly for cardiogenic shock. (urosario.edu.co)
IABP2
- IABP counterpulsation was strongly recommended for both treatment arms. (medscape.com)
- The IABP is a form of internal counterpulsation acting as an assistive circulatory support device through diastolic augmentation during inflation-enhancing coronary, cerebral, and systemic perfusion. (frontiersin.org)
Efficacy1
- Efficacy of counterpulsation: Model and experiment" by D. Jaron, W. Ohley et al. (uri.edu)
Cardiac2
- Counterpulsation is an important support for patients with cardiac diseases. (biomedcentral.com)
- Previously the Company announced that data from a study presented at the recently convened Annual Congress of the Swiss Society of Cardiology concluded that "MCP (Muscular CounterPulsation) is safe and efficient for improving cardiac function" non-surgically in patients with coronary artery disease (CAD). (medlatest.com)
Cuffs1
- External Counterpulsation works by mechanically inflating air in cuffs that are placed on the body's extremities inflating at the calves, thighs and buttucks areas in a sequential order physically squeezing blood back to the heart on each heart cycle. (ecptherapy.com)
Treatment1
- We are extremely pleased with our headway in penetrating the European market with our breakthrough m.pulse ® system, based on Muscular CounterPulsation or MCP, for the non-surgical treatment of Coronary Artery Disease. (medlatest.com)
Blood flow1
- This well-established Muscular CounterPulsation action results in increased blood flow to the heart muscle while decreasing the heart's workload. (medlatest.com)
Heart failure1
- Studies on External Counterpulsation as a Potential Measure for Acute Left Heart Failure. (nih.gov)
Results1
- Aortomyoplasty might achieve better results, working on the much smaller aortic diameter, and contracting in diastole to create counterpulsation. (bmj.com)